Department of Public Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
Kidney Int. 2011 Dec;80(12):1306-14. doi: 10.1038/ki.2011.280. Epub 2011 Aug 17.
The estimated glomerular filtration rate (eGFR) is a powerful predictor of adverse outcomes, but most attention has focused on studies in the setting of reduced eGFR. Here we tested whether patients with an eGFR higher than 60-89.9 ml/min per 1.73 m(2) could also be at elevated risk of adverse outcomes. Further, we tested whether concomitant proteinuria further increases the risk of outcomes among individuals with an eGFR equal to or above 90 ml/min per 1.73 m(2), as it does for those with reduced eGFR. Using data from a population-based outpatient laboratory data set of 1,526,437 patients, we measured adjusted associations between eGFR calculated by the modification of diet in renal disease equation, urine dipstick proteinuria, and adverse clinical outcomes. The adjusted risk of all-cause mortality was lowest at an eGFR of 60-74.9 ml/min per 1.73 m(2) (referent) and increased at both lower and higher levels of eGFR. Specifically, the hazard ratio of death was 3.7 and 1.8 among patients with an eGFR equal to or above 105 and 90-104.9 ml/min per 1.73 m(2), respectively, compared to the referent group. Similar results were seen when the CKD-EPI equation (sensitivity analyses) was used to assess eGFR. Higher levels of eGFR were not associated with the risk of kidney failure or myocardial infarction. Thus, the presence and severity of proteinuria was significantly associated with graded increases in the risk of clinical outcomes for both lower and higher eGFR. We do not know, however, whether the finding at higher eGFR could be due to inadequacies of the eGFR formula at low serum creatinine levels.
估算肾小球滤过率(eGFR)是不良结局的有力预测指标,但大多数研究都集中在 eGFR 降低的情况下。在这里,我们测试了 eGFR 高于 60-89.9ml/min/1.73m(2)的患者是否也存在不良结局的风险增加。此外,我们还测试了在 eGFR 等于或高于 90ml/min/1.73m(2)的个体中,蛋白尿的同时存在是否会进一步增加结局风险,就像在 eGFR 降低的个体中一样。我们使用来自基于人群的门诊实验室数据集中的 1,526,437 名患者的数据,测量了改良肾脏病饮食方程(modification of diet in renal disease equation)计算的 eGFR、尿试纸蛋白尿与不良临床结局之间的调整关联。全因死亡率的调整风险在 eGFR 为 60-74.9ml/min/1.73m(2)(参照组)时最低,在 eGFR 较低和较高水平时均增加。具体来说,与参照组相比,eGFR 等于或高于 105 和 90-104.9ml/min/1.73m(2)的患者死亡的危险比分别为 3.7 和 1.8。当使用 CKD-EPI 方程(敏感性分析)评估 eGFR 时,也得到了类似的结果。较高的 eGFR 与肾衰竭或心肌梗死的风险无关。因此,蛋白尿的存在和严重程度与较低和较高 eGFR 的临床结局风险的分级增加显著相关。然而,我们不知道较高 eGFR 的发现是否是由于血清肌酐水平较低时 eGFR 公式的不足所致。